Antiandrogens compete with androgens for the androgen receptor (AR) within the target organ. However, the precise molecular mechanism of their antagonism is not well understood. In this paper we describe the use of limited trypsinization and sucrose density gradient centrifugation for the study of androgen receptor conformation and interaction with other proteins.
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For this purpose, an in vitro-produced, [35S]methionine-labeled AR was complexed with ligand at 2 5 T , whereafter limited trypsinization was performed. Subsequently, the AR fragments were analyzed on a polyacrylamide gel. A 29-kDa fragment of an androgen-bound receptor showed an increased resistance against trypsinization, as compared to an unliganded AR. The antiandrogen cyproterone acetate stabilized a 35-kDa fragment of the AR against proteolytic degradation (FIG. 1 (FIG. 1) . These results indicate a difference in interaction with the AR between the common antiandrogens and RU 486. lmmunoprecipitation with a panel of antibodies against the androgen receptor showed that both the 35-and 29-kDa fragments contained the entire ligand binding domain, while the 35-kDa fragment extended into the hinge region.2 The 25-kDa fragment was truncated at the C-terminus of the ligand binding domain, which conforms to results obtained in comparable studies on protease susceptibility for the progesterone receptor complexed with RU 486.4 When incubation was performed at 0°C (FIG. 2) , or in the presence of molybdate, both androgens and most antiandrogens stabilized a 35-kDa fragment of the AR. In the presence of RU 486 a 35-kDa and 30-kDa fragment of the AR resisted trypsinization. These results indicate a change in proteolysis resisting conformation of the AR upon warming from 0°C to 25°C for androgens and RU 486, but not for the other antiandrogens. The conformational change of the AR may reflect a process accompanying the dissociation of heat shock proteins (hsp) from the nonactivated hsp-receptor complex. Indeed, sucrose gradient centrifugation showed that an 8S- receptor complex shifted, upon warming, to a 5s complex in the presence of androgens and to a 4s complex with RU 486. In the presence of other antiandrogens, an 8S-receptor complex was still present after warming (results not shown).
In conclusion: most antiandrogens increased the stability of the conformation around the hinge region of an in vitro-produced androgen receptor, and did not dissociate the hsp-receptor complex. RU 486, when bound to the androgen receptor, induced an inappropriate conformation at the C-terminus of the ligand binding domain and formed a complex with the receptor with a slower sedimentation rate than observed for complexes with agonists. 
